Recombinant Human Anti-CD3 x Human Anti-FcRH5 Bispecific Antibody (scFv-CH1/CL) (BSCC-H257)

Recombinant Anti-CD3 x Anti-FcRH5 Bispecific Antibody (scFv-CH1/CL) is designed to be expressed as two chains. One scFv from an anti-CD3 antibody variable domain is fused to CH1 and the other scFv from an anti-FcRH5 antibody variable domain fused to CL, or vice versa. And the CH1 and CL domains are linked covalently via a natural disulfide bond. This BsAb can retarget T cells to tumor cells. It is designed for the research of Multiple myeloma (MM); B cell malignancies therapy.

Datasheet INQUIRY

Specifications

Targets

CD3 & FcRH5

Type

scFv-based Bispecific Fragments

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Multiple myeloma (MM); B cell malignancies

Targets

Target 1

CD3

Gene ID

916

UniProt ID

P07766

Alternative Names

CD3; CD3E; CD3e molecule; Cluster of differentiation 3; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3

Target 2

FcRH5

Gene ID

83416

UniProt ID

Q96RD9

Alternative Names

FCRL5; Fc receptor like 5; CD307; FCRH5; IRTA2; BXMAS1; CD307e; PRO820

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Human Anti-CD3 x Human Anti-FcRH5 Bispecific Antibody (scFv-CH1/CL) (BSCC-H257). Click the button below to contact us or submit your feedback about this product.

Recombinant Human Anti-CD3 x Human Anti-FcRH5 Bispecific Antibody (scFv-CH1/CL) (CAT#: BSCC-H257)

Specifications

Targets

Customer Reviews and Q&As